{"id":510,"date":"2016-02-20T08:36:12","date_gmt":"2016-02-20T14:36:12","guid":{"rendered":"http:\/\/www.masstortlawyerblog.com\/?p=510"},"modified":"2018-04-23T11:48:53","modified_gmt":"2018-04-23T16:48:53","slug":"xarelto-mdl-judge-issues-order-limited-discovery-proceed","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/xarelto-mdl-judge-issues-order-limited-discovery-proceed\/","title":{"rendered":"Xarelto MDL Judge Issues Order For Limited Discovery to Proceed"},"content":{"rendered":"

For many of us, pharmaceuticals can offer a life-saving alternative to suffering from terrible conditions and injuries.\u00a0In some unfortunate situations, however, certain pharmaceutical companies fail to appropriately design, manufacture, and market their drug products. One such example is Xarelto, a\u00a0drug that is designed as a blood thinner. Now, thousands of lawsuits alleging health problems associated with taking Xarelto are pending<\/a> in a multi-district litigation proceeding in the Eastern District of Louisiana.<\/p>\n

The U.S. Food and Drug Administration (“FDA”) approved the drug for administration to\u00a0patients who\u00a0underwent knee or hip replacements to help reduce blood clots and associated risks.\u00a0In the fall of 2011, the FDA broadened the approval of Xarelto to help treat patients who\u00a0experience an irregular heartbeat, also known as atrial fibrillation. It is currently believed that millions of individuals have been prescribed Xarelto since it first hit the market.<\/p>\n

Some patients taking Xarelto have reported suffering severe health consequences associated with the drug. Blood thinners can cause unwanted gastrointestinal bleeding and other conditions of a hemorrhaging nature. In response to these issues, the FDA issued two black box warnings. This is the strictest warning that the FDA can impose on a pharmaceutical product. To assign a black box warning, the FDA must find reasonable evidence that the drug is associated with a serious hazard.<\/p>\n

Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

For many of us, pharmaceuticals can offer a life-saving alternative to suffering from terrible conditions and injuries.\u00a0In some unfortunate situations, however, certain pharmaceutical companies fail to appropriately design, manufacture, and market their drug products. One such example is Xarelto, a\u00a0drug that is designed as a blood thinner. Now, thousands of lawsuits alleging health problems associated […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-510","post","type-post","status-publish","format-standard","hentry","category-pharmaceuticals"],"yoast_head":"\nXarelto MDL Judge Issues Order For Limited Discovery to Proceed — Illinois Injury and Mass Tort Lawyer Blog — February 20, 2016<\/title>\n<meta name=\"description\" content=\"For many of us, pharmaceuticals can offer a life-saving alternative to suffering from terrible conditions and injuries.\u00a0In some unfortunate situations, — February 20, 2016\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/xarelto-mdl-judge-issues-order-limited-discovery-proceed\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Xarelto MDL Judge Issues Order For Limited Discovery to Proceed — Illinois Injury and Mass Tort Lawyer Blog — February 20, 2016\" \/>\n<meta name=\"twitter:description\" content=\"For many of us, pharmaceuticals can offer a life-saving alternative to suffering from terrible conditions and injuries.\u00a0In some unfortunate situations, — February 20, 2016\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xarelto MDL Judge Issues Order For Limited Discovery to Proceed — Illinois Injury and Mass Tort Lawyer Blog — February 20, 2016","description":"For many of us, pharmaceuticals can offer a life-saving alternative to suffering from terrible conditions and injuries.\u00a0In some unfortunate situations, — February 20, 2016","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/xarelto-mdl-judge-issues-order-limited-discovery-proceed\/","twitter_card":"summary_large_image","twitter_title":"Xarelto MDL Judge Issues Order For Limited Discovery to Proceed — Illinois Injury and Mass Tort Lawyer Blog — February 20, 2016","twitter_description":"For many of us, pharmaceuticals can offer a life-saving alternative to suffering from terrible conditions and injuries.\u00a0In some unfortunate situations, — February 20, 2016","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/xarelto-mdl-judge-issues-order-limited-discovery-proceed\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/xarelto-mdl-judge-issues-order-limited-discovery-proceed\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"Xarelto MDL Judge Issues Order For Limited Discovery to Proceed","datePublished":"2016-02-20T14:36:12+00:00","dateModified":"2018-04-23T16:48:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/xarelto-mdl-judge-issues-order-limited-discovery-proceed\/"},"wordCount":547,"articleSection":["Pharmaceuticals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/xarelto-mdl-judge-issues-order-limited-discovery-proceed\/","url":"https:\/\/www.molllawgroup.com\/blog\/xarelto-mdl-judge-issues-order-limited-discovery-proceed\/","name":"Xarelto MDL Judge Issues Order For Limited Discovery to Proceed — Illinois Injury and Mass Tort Lawyer Blog — February 20, 2016","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"datePublished":"2016-02-20T14:36:12+00:00","dateModified":"2018-04-23T16:48:53+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"For many of us, pharmaceuticals can offer a life-saving alternative to suffering from terrible conditions and injuries.\u00a0In some unfortunate situations, — February 20, 2016","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/xarelto-mdl-judge-issues-order-limited-discovery-proceed\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/xarelto-mdl-judge-issues-order-limited-discovery-proceed\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/xarelto-mdl-judge-issues-order-limited-discovery-proceed\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Xarelto MDL Judge Issues Order For Limited Discovery to Proceed"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=510"}],"version-history":[{"count":2,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/510\/revisions"}],"predecessor-version":[{"id":2236,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/510\/revisions\/2236"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=510"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=510"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}